Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ROIV | INSM | INCY | ||
| Company | Roivant Sciences Ltd | Insmed Inc | Incyte Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 36.91 | 128.36 | 127.10 | ||
| High | 37.55 | 130.27 | 129.80 | ||
| Low | 36.68 | 124.60 | 126.71 | ||
| Last | 36.84 | 125.08 | 127.22 | ||
| Change | -0.56 | -5.58 | -1.25 | ||
| Percent Change | -1.50% | -4.27% | -0.97% | ||
| Volume | 3,127,800 | 1,761,800 | 1,207,100 | ||
| 20-Day Average Volume | 5,631,130 | 3,134,035 | 1,879,375 | ||
| Previous | 37.40 | 130.66 | 128.47 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 35.32 | 117.05 | 122.03 | ||
| 20-Day Raw Stochastic | 79.45% | 69.43% | 68.03% | ||
| 20-Day Relative Strength | 59.85 | 57.19 | 63.07 | ||
| Weighted Alpha | +180.92 | -17.90 | +54.70 | ||
| Today's Opinion | 100% Buy | 24% Sell | 100% Buy | ||
| Yesterday's Opinion | 100% Buy | 8% Sell | 100% Buy | ||
| Last Month's Opinion | 88% Buy | 56% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.54% since 08/13/26 | -0.99% since 08/13/26 | +5.56% since 08/13/26 | ||
| Low | 35.65 on 08/17/26 | 122.21 on 08/14/26 | 117.56 on 08/14/26 | ||
| High | 37.97 on 08/19/26 | 131.10 on 08/19/26 | 129.80 on 08/20/26 | ||
| 1-Month | |||||
| %Chg | +8.19% since 07/20/26 | +16.88% since 07/20/26 | +10.00% since 07/20/26 | ||
| Low | 32.47 on 08/03/26 | 96.42 on 08/03/26 | 114.50 on 07/23/26 | ||
| High | 37.97 on 08/19/26 | 137.70 on 08/06/26 | 132.60 on 07/28/26 | ||
| 3-Month | |||||
| %Chg | +13.67% since 05/20/26 | +15.91% since 05/20/26 | +31.05% since 05/20/26 | ||
| Low | 27.92 on 06/02/26 | 90.39 on 06/10/26 | 92.18 on 06/02/26 | ||
| High | 37.97 on 08/19/26 | 137.70 on 08/06/26 | 132.60 on 07/28/26 | ||
| 6-Month | |||||
| %Chg | +35.69% since 02/20/26 | -24.15% since 02/20/26 | +25.56% since 02/20/26 | ||
| Low | 25.95 on 03/30/26 | 90.39 on 06/10/26 | 89.25 on 03/24/26 | ||
| High | 37.97 on 08/19/26 | 167.00 on 02/23/26 | 132.60 on 07/28/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 27,014,880 | 28,533,792 | 26,040,610 | ||
| Shares Outstanding, K | 722,323 | 218,382 | 202,698 | ||
| Annual Sales, $M | 8,260,000 | 606,420,000 | 5,141,240,000 | ||
| Annual Net Income, $M | -299,770,000 | -1,276,780,000 | 1,286,650,000 | ||
| Last Qtr Sales, $M | 1,440,000 | 425,490,000 | 1,674,040,000 | ||
| Last Qtr Income, $M | -189,840,000 | -13,240,000 | 585,610,000 | ||
| 60-Month Beta | 1.12 | 0.81 | 0.76 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.33 on 08/06/26 | -0.52 on 08/06/26 | 3.09 on 07/28/26 | ||
| Latest Earnings Date | 11/09/26 | 10/29/26 | 10/27/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 15.55 | ||